| Followers | 843 |
| Posts | 123010 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Saturday, November 05, 2022 12:59:56 PM
https://finance.yahoo.com/news/zimmer-biomet-announces-one-data-120000697.html
Zimmer Biomet Holdings…today announced one-year data from a multicenter, prospective, randomized controlled trial to evaluate the impact of mymobility with Apple Watch, a first-of-its-kind remote care management platform. The data show that using mymobility with Apple Watch following primary knee arthroplasty, commonly known as knee replacement, can effectively guide rehabilitation, demonstrate similar outcomes to traditional care models, and significantly reduce the number of outpatient physical therapy (PT) visits.
In addition, use of mymobility with Apple Watch was associated with significantly fewer surgery-related emergency department (ED) visits, which could translate to lower costs of care. The data will be presented at a podium session at the 2022 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS).
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ZBH News
- Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026 • PR Newswire (US) • 05/22/2026 08:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 07:19:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 06:47:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 10:30:17 AM
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End • PR Newswire (US) • 05/12/2026 10:30:00 AM
- Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference • PR Newswire (US) • 05/06/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:08:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/01/2026 09:11:37 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 06:48:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 10:33:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 10:30:16 AM
- Zimmer Biomet Announces First Quarter 2026 Financial Results • PR Newswire (US) • 04/28/2026 10:30:00 AM
- Zimmer Biomet Announces Chief Financial Officer Transition • PR Newswire (US) • 04/28/2026 10:29:00 AM
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results • PR Newswire (US) • 04/09/2026 11:30:00 AM
- Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer • PR Newswire (US) • 04/07/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:03:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:20:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:19:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:18:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:17:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:17:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:16:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:13:58 PM
